002 AZ LN VN Apr 2020

Baseline UK real-world study in ovarian cancer pre-PARPi published

A study was published recently on the real-world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors as a result of a collaboration between AstraZeneca and SVMPharma The study, aside from providing a baseline for future evaluations to […]

Read More
002 BR Feb 2020

Introduction of e-prescribing in cancer improved safety 10-fold

Electronic prescribing records were introduced as they offer vastly improved communication between different healthcare professionals and patients, which was found to be the source of a high proportion of prescribing errors A study was carried out at St Bartholomew’s Hospital, London to assess whether or not the introduction of electronic prescribing led to improved patient […]

Read More
001 BR Mar 2020

Wearable tech is providing a wealth of untapped real-world data

In the last 20 years, connected digital device use has grown approximately 32% per year, with a huge number of people using smart phones & fitness trackers. Each of these devices is recording current, real-time data Already medical applications are revealing themselves; for example, wearable devices that provide continuous blood glucose testing in diabetic patients […]

Read More